Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06040567
What this trial is testing

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Vasculitic NeuropathyPOEMS Syndrome+6 more
Rigshospitalet, Denmark 520
Testing effectiveness (Phase 2)Study completedNCT00001287
What this trial is testing

Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Demyelinating DiseasesParaproteinemias
National Institute of Neurological Disorders and Stroke (NINDS) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07027111
What this trial is testing

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Nuvig Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07032662
What this trial is testing

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH 162
Testing effectiveness (Phase 2)Study completedNCT03861481
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
UCB Biopharma S.P.R.L. 34
Not applicableStudy completedNCT00305266
What this trial is testing

Study of CIDP Patients During IVIG Treatment

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
University of Aarhus 11
Post-approval studies (Phase 4)Active Not RecruitingNCT06620198
What this trial is testing

Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome

Who this might be right for
Guillain Barré Syndrome
I.R.C.C.S. Fondazione Santa Lucia 62
Large-scale testing (Phase 3)Study completedNCT01824251
What this trial is testing

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Nihon Pharmaceutical Co., Ltd 49
Not applicableAvailableNCT04777734
What this trial is testing

Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CIDP
argenx
Not applicableLooking for participantsNCT06183645
What this trial is testing

Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Centre Hospitalier Universitaire de Liege 40
Large-scale testing (Phase 3)UnknownNCT03166527
What this trial is testing

Panzyga in CIDP Administered at Different Infusion Rates

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Vera Bril 30
Post-approval studies (Phase 4)WithdrawnNCT01757574
What this trial is testing

Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)

Who this might be right for
Chronic Inflammatory Demyelinating Neuropathy
Johns Hopkins University
Not applicableUnknownNCT02271724
What this trial is testing

SCD163 & CD19 as Candidate Biomarkers in CIDP and MMN

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
University of Aarhus 85
Large-scale testing (Phase 3)Study completedNCT01625182
What this trial is testing

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Novartis Pharmaceuticals 106
Not applicableEnded earlyNCT05492604
What this trial is testing

Comparison of FEETME® Soles and GAITRITE® Walkway for the Evaluation of Gait Disorders in CIDP.

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
University Hospital, Bordeaux 18
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07638566
What this trial is testing

Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating PolyradiculoneuropathyCIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)CIDP+1 more
argenx 6
Not applicableStudy completedNCT02121678
What this trial is testing

Effect of Resistance and Aerobic Exercise in CIDP or MMN

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyMultifocal Motor Neuropathy
University of Aarhus 23
Testing effectiveness (Phase 2)Ended earlyNCT07188844
What this trial is testing

An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH 26
Testing effectiveness (Phase 2)Ended earlyNCT05581199
What this trial is testing

To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH 94
Next Page